| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |